Quilonum Sr

Quilonum Sr

Dosage
300mg
Package
30 pill 60 pill 90 pill 120 pill 180 pill 360 pill
Total price: 0.0
  • In our pharmacy, you can buy quilonum sr without a prescription, with delivery in 5–14 days throughout Australia. Discreet and anonymous packaging.
  • Quilonum sr is intended for the treatment of bipolar disorder and mood stabilization. The drug works as a psycholeptic by moderating neurotransmitter activity in the brain.
  • The usual dose of quilonum sr is typically 600–1200 mg/day, depending on the specific condition being treated.
  • The form of administration is a tablet.
  • The effect of the medication begins within 1–2 weeks for mood stabilisation, with adjustments based on clinical response.
  • The duration of action varies, but the therapeutic effects can last for several hours, requiring divided doses throughout the day.
  • Do not consume alcohol.
  • The most common side effect is fine tremor.
  • Would you like to try quilonum sr without a prescription?
Trackable delivery 9-21 days
Payment method Visa, MasterCard, Discovery, AMEX, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over A$305

Basic Quilonum SR Information

  • INN (International Nonproprietary Name): Lithium carbonate
  • Brand names available in Australia: Quilonum
  • ATC Code: N05AN01
  • Forms & dosages: Tablets (450 mg, 600 mg), solutions
  • Manufacturers in Australia: Multiple generic manufacturers
  • Registration status in Australia: Prescription Only (Rx)
  • OTC / Rx classification: Prescription Only

Critical Warnings & Restrictions

Safety is paramount while using Quilonum SR (Lithium carbonate). Patients should consult a healthcare professional before starting this medication, especially if they belong to high-risk groups such as the elderly, pregnant women, or those with chronic illnesses. Monitoring for early signs of toxicity is essential, as these may occur even at therapeutic levels.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Elderly patients, pregnant women, and those with chronic illnesses must be closely monitored due to their increased susceptibility to adverse effects. Failure to administer adequate surveillance may lead to serious consequences, which underscores the importance of regular health check-ups when on Quilonum SR.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Patients should refrain from engaging in activities that require high levels of alertness, such as driving or operating heavy machinery, until they fully understand how Quilonum affects them. Australian law mandates that health professionals advise patients on potential impairments associated with this medication. Such precautions are vital to ensure patient safety and adhere to workplace regulations.

Q&A — “Can I Drive After Taking It in Australia?”

Q: Can I drive after taking Quilonum SR?
A: It's crucial to assess your response to the medication first. Consult your doctor about when it is safe for you to drive.

Access & Purchase Options

Quilonum SR is widely available across Australia, offering various purchasing options for patients needing mood stabilisation. Accessing this medication, commonly used for bipolar disorder, can be straightforward, depending on the individual's location and needs.

National Chains (Chemist Warehouse, Priceline, TerryWhite)

Major pharmacy chains like Chemist Warehouse and Priceline typically stock Quilonum SR. However, availability can vary from one location to another. Shoppers are advised to check with their local store beforehand to avoid disappointment. These national chains often feature competitive pricing, making it a practical choice for many seeking accessible treatment.

Online Pharmacies and Telehealth E-prescriptions

For those in rural or remote areas, online pharmacies serve as a convenient option to obtain Quilonum SR. Australians can access telehealth services that offer e-prescriptions through online consultations, facilitating timely access to necessary medications. This is especially useful for individuals managing bipolar disorder, ensuring they remain compliant with their treatment plans without the need for extensive travel.

Mechanism & Pharmacology

A clear understanding of Quilonum SR's pharmacological action is essential for contextualising its role in treating mood disorders. The medication plays a significant role in stabilising mood and preventing manic episodes by influencing neurotransmitter functioning.

Simplified Explanation

Quilonum SR contains lithium carbonate, which modulates neurotransmitter levels and stabilises mood. It works by altering sodium transport across neuronal membranes, a crucial mechanism for effective neurotransmission. This action helps regulate mood swings commonly associated with bipolar disorder.

Clinical Terms

Within the context of psychopharmacology, Quilonum SR is classified as an antimanic agent. Its primary role is in treating acute mania and providing maintenance therapy for bipolar disorder. Regular monitoring of serum lithium levels is vital due to the drug’s narrow therapeutic range and the associated risk of toxicity.

Indications & Off-Label Uses

Understanding the indications for Quilonum SR, along with any potential off-label uses, can significantly enhance treatment planning for healthcare providers. Awareness of these applications is crucial in optimising patient care and therapeutic outcomes.

Approved Indications by TGA

In Australia, Quilonum SR is approved by the Therapeutic Goods Administration (TGA) for the treatment of acute mania and long-term maintenance therapy in patients with bipolar disorder. It is considered a cornerstone medication for effective management strategies in affected individuals.

Off-Label Uses in Australian Clinical Practice

Beyond its approved uses, Quilonum SR may also be applied off-label in managing treatment-resistant unipolar depression. This potential is particularly noted for its antisuicidal properties, which healthcare providers may explore in resistant cases.

Key Clinical Findings

Recent clinical studies underscore the effectiveness of Quilonum SR in stabilising mood among patients with bipolar disorder. These findings highlight its continued relevance in modern mental health care.

Major Findings: Research conducted from 2022 to 2025 demonstrates consistently positive outcomes associated with Quilonum SR. Studies reaffirm its efficacy in stabilising mood, reducing the frequency of manic episodes while emphasising the necessity of regular monitoring for optimal treatment results.

Alternatives Matrix

A variety of alternatives to Quilonum SR are available for managing mood disorders, each with its own set of benefits and constraints. Understanding these alternatives can assist in tailoring treatments to patient needs.

PBS-Listed Alternatives Comparison Table

Medication Form Indication Notes
Lithobid Extended-release tablet Bipolar disorder Similar effectiveness
Valproic acid Tablet Bipolar disorder May have different side effects
Carbamazepine Tablet Bipolar disorder Monitoring needed for levels

Pros and Cons Checklist

  • Pros of alternatives: Often available in multiple forms and tailored to patient needs.
  • Cons: Each alternative comes with different side effects and interactions; some may not have a comprehensive evidence base compared to lithium.

Common Questions

A collection of frequently asked questions can enhance patient understanding.

  • What is Quilonum SR used for? It treats bipolar disorder, helping stabilise mood during manic episodes.
  • How long does it take to work? Patients might experience full effects within weeks, necessitating consistent monitoring during initial management stages.
  • Can I stop taking it suddenly? Abrupt cessation is discouraged due to withdrawal risks; consult your doctor first.

Suggested Visual Content

Adding visual aids enhances user engagement and educational value.

  • Infographics: Outline PBS pricing structures, showing how Quilonum SR fits within the broader healthcare system.
  • Pharmacy Network Map: Illustrate the availability of Quilonum SR across urban and rural pharmacies, highlighting regional access disparities.

Registration & Regulation

Understanding Quilonum's registration and regulatory status ensures compliance with Australian health standards.

TGA Approval

Quilonum SR is registered with the TGA, adhering to strict criteria for safety, efficacy, and quality. Continuous monitoring post-approval ensures it meets ongoing safety assessments in practice.

PBS Subsidy Details

Listed under the PBS, patients fulfilling eligibility criteria can access Quilonum SR at subsidised rates, enhancing medication accessibility. Users should discuss with their prescriber about their entitlement under the PBS guidelines.

Storage & Handling

Proper storage ensures the integrity of Quilonum SR throughout its shelf life.

Household Storage in Australian Climate (heat/humidity)

Store Quilonum SR at room temperature (20-25°C), shielded from moisture and heat. Common Australian climate fluctuations may impact stability, hence a cool, dry location is advisable.

Cold-Chain Handling for Pharmacies

Pharmacies must adhere to cold-chain protocols during transportation to preserve medication effectiveness. Healthcare professionals should ensure proper handling practices are in place for medications requiring special conditions.

Guidelines for Proper Use

Emphasising patient education supports safe and effective medication use.

Australian Pharmacist Counselling Style

Pharmacists play a vital role in educating patients about Quilonum SR, covering usage instructions, potential side effects, and interactions to facilitate informed decision-making. They must create an environment that encourages patients to ask questions and express concerns.

Patient Advice from PBS and National Health Authorities

Patients are encouraged to actively engage in their treatment plans by considering lifestyle factors impacting mental health. Consult the PBS for reliable information and guidance regarding medication adherence practices, regular check-ups, and monitoring requirements.

Pharmacy Delivery Times Across Major Cities

City Region Delivery Time
Sydney New South Wales 5–7 days
Melbourne Victoria 5–7 days
Brisbane Queensland 5–7 days
Perth Western Australia 5–7 days
Adelaide South Australia 5–7 days
Hobart Tasmania 5–9 days
Canberra Australian Capital Territory 5–7 days
Darwin Northern Territory 5–9 days
Gold Coast Queensland 5–7 days
Newcastle New South Wales 5–9 days
Sunshine Coast Queensland 5–9 days
Cairns Queensland 5–9 days